BIOMAT Database Logo BIOMAT Database Logo

Review of eprosartan: a new angiotensin II receptor antagonist. Summary. 1999

D A Sica
Department of Clinical Pharmacology and Hypertension, Medical College of Virginia of Virginia Commonwealth University, Richmond 23298-1060, USA.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D057911 Angiotensin Receptor Antagonists Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. Angiotensin II Receptor Antagonist,Angiotensin II Receptor Blocker,Angiotensin Receptor Antagonist,Angiotensin Receptor Blocker,Angiotensin II Receptor Antagonists,Angiotensin II Receptor Blockers,Angiotensin Receptor Blockers,Antagonist, Angiotensin Receptor,Antagonists, Angiotensin Receptor,Blocker, Angiotensin Receptor,Receptor Antagonist, Angiotensin,Receptor Antagonists, Angiotensin,Receptor Blocker, Angiotensin,Receptor Blockers, Angiotensin

Related Publications

D A Sica
Review of eprosartan: a new angiotensin II receptor antagonist. Introduction.
April 1999, Pharmacotherapy,
D A Sica
Eprosartan mesylate, an angiotensin II receptor antagonist.
April 2011, Acta crystallographica. Section E, Structure reports online,
D A Sica
Pharmacology of the angiotensin II receptor antagonist, eprosartan.
March 1998, Expert opinion on investigational drugs,
D A Sica
Eprosartan: an angiotensin-II receptor antagonist for the management of hypertension.
January 2002, Heart disease (Hagerstown, Md.),
D A Sica
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker.
September 1999, American heart journal,
D A Sica
Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data.
September 1999, American heart journal,
D A Sica
Clinical profile of eprosartan: a different angiotensin II receptor blocker.
October 2008, Cardiovascular & hematological agents in medicinal chemistry,
D A Sica
Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan.
November 2000, Physiological genomics,
D A Sica
Comparison of office and ambulatory blood pressure measurements to assess the angiotensin II receptor antagonist eprosartan.
February 1996, Blood pressure monitoring,
D A Sica
Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
March 1999, Clinical therapeutics,
Copied contents to your clipboard!